MYCN and prostate adenocarcinoma: Amplification and overexpression of MYCN and AURKA genes have been observed in confirmed t-NEPC tissue, and both induce a neuroendocrine cell phenotype in prostatic adenocarcinoma cells through transcriptional reprogramming mechanisms (Mosquera et al., 2013; Dardenne et al., 2016).